Name | dehydrobruceine B |
---|
Description | Dehydrobruceine B, a quassinoid, can be isolated from Brucea javanica. Dehydrobruceine B shows a synergistic effect with Cisplatin (HY-17394) to induce apoptosis via mitochondrial method. Dehydrobruceine B increases apoptosis-inducing factor (AIF) and Bax expression and suppresses Keap1-Nrf2[1]. |
---|---|
Related Catalog | |
Target |
Bax Bcl-xL Bcl-2 |
In Vitro | Dehydrobruceine B (1 μM; 48 h) 和 Cisplatin (3-18 μM; 48 h) 在 A549 细胞中具有协同作用,致使细胞毒性和凋亡效应[1]。 Dehydrobruceine B (1 μM; 24 h) 在 Cisplatin (3 μM, 6 μM; 24 h) 处理的A549细胞中,诱导胞内 ROS 产生[1]。 Dehydrobruceine B (3 μM, 6 μM; 24 h) 在 Cisplatin (3 μM, 6 μM; 24 h) 处理的A549细胞中,促进线粒体膜电位 (MMP) 的去极化和细胞色素 c 的易位[1]。 Dehydrobruceine B (1 μM; 24 h) 增强 A549 细胞抗凋亡和促凋亡蛋白水平的变化[1]。 Western Blot Analysis[1] Cell Line: A549 cells Concentration: 1 μM; with or without Cisplatin Incubation Time: 48 hours Result: Upregulated the protein level of Bax, while downregulated the levels of Bcl-2 and Bcl-xL. Enhanced caspase activation and PARP cleavage. Apoptosis Analysis[1] Cell Line: A549 cells Concentration: 1 μM; with or without Cisplatin Incubation Time: 48 hours Result: Inhibited cell viability with 9 μM and 18 μM Cisplatin, respectively. Induced cell apoptosis with 3 μM and 6 μM Cisplatin, respectively. Immunofluorescence[1] Cell Line: A549 cells Concentration: 1 μM; with or without 3 μM and 6 μM Cisplatin, respectively Incubation Time: 24 hours Result: Resulted apoptosis-inducing factor (AIF) translocated from cytosol into nucleus dramatically in the co-treatment condition. |
References |
Molecular Formula | C23H26O11 |
---|---|
Molecular Weight | 478.45 |